Atlas Trials

Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors

Clinical trial NCT04571632 · UNKNOWN

Trial details

NCT number
NCT04571632
Sponsor
Universitair Ziekenhuis Brussel
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung CancerSolid Tumor
Start date
2020-09-22
Primary completion
2023-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.